[Controversies in the follow-up and management of well-differentiated thyroid cancer. New answers to old questions].
Abós Olivares
M D
MD
Servicio de Medicina Nuclear, Hospital Clínico Universitario Lozano Blesa, Zaragoza. mnup-abos@hcu-lblesa.es
Pesquera González
C
C
D018263:Adenocarcinoma, Follicular / Q000097:blood / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D001323:Autoantibodies / Q000097:blood; D014408:Biomarkers, Tumor / Q000097:blood; D002291:Carcinoma, Papillary / Q000097:blood / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D019090:Case Management; D005500:Follow-Up Studies; D006801:Humans; D007457:Iodine Radioisotopes / Q000008:administration & dosage / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals; D011879:Radiotherapy Dosage; D011994:Recombinant Proteins / Q000494:pharmacology; D012306:Risk; D013954:Thyroglobulin / Q000097:blood; D013964:Thyroid Neoplasms / Q000097:blood / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D013965:Thyroidectomy; D013972:Thyrotropin / Q000097:blood / Q000494:pharmacology
D001323:Autoantibodies; D014408:Biomarkers, Tumor; D007457:Iodine Radioisotopes; D019275:Radiopharmaceuticals; D011994:Recombinant Proteins; C006606:anti-thyroglobulin; D013972:Thyrotropin; D013954:Thyroglobulin